Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for Preventing Spinal Anesthesia-Induced Hypotension
NCT04703088Phase 3Unknown
- Sponsor
- Université Laval
- Start
- Jun 2021
- Primary completion
- Aug 2021
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of ondansetron in hypotension (2 arms), sponsored by Université Laval. Primary endpoint: Effective Dose in 50% of subjects of prophylactic norepinephrine. Status: unknown.
02
Drugs
ondansetron
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT04703088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04703088.